Adenocarcinoma is a subtype of NSCLC ... It accounts for about 10% to 15% of lung cancers. Immunotherapy is a newer treatment for cancer that uses a person’s immune system to help the body ...

Akeso and Summit Therapeutics’ giant-killing, PD-1xVEGF bispecific antibody ivonescimab has posted another phase 3 trial win ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Scientists have discovered a new weakness in lung cancer that could lead to better treatments and help prevent the disease ...

This is important to understand, as it can drive treatment protocols ... on sugar for growth compared to other subtypes, such as lung adenocarcinoma. Studies like the one mentioned above have ...